BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-0.94%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$498M
AUM Growth
+$498M
(-6.2%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-25.45%
Top 10 Holdings %
Top 10 Hldgs %
75.53%
Holding
33
New
4
Increased
9
Reduced
10
Closed
4
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$13.8M |
| 2 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$10M |
| 3 |
Fate Therapeutics
FATE
|
$9.44M |
| 4 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$3.66M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$2.79M |
Top Sells
| 1 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$15.9M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$13M |
| 3 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$10.2M |
| 4 |
Protagonist Therapeutics
PTGX
|
$7.92M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$1.96M |
Sector Composition
| 1 | Healthcare | 76.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OREX
26
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.28M | 0.26% |
734,976
| – | – |
|
27
Xoma
XOMA
$421M
| $1.28M | 0.26% |
+302,800
| New | +$1.28M |
|
|
ANTH
28
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $40K | 0.01% |
+62,292
| New | +$40K |
|
|
GBIM
29
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
| – | – |
-657,653
| Closed | -$822K |
|
|
TBRA
30
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| – | – |
-399,433
| Closed | -$15.9M |
|
|
31
Protagonist Therapeutics
PTGX
$3.62B
| – | – |
-375,000
| Closed | -$7.92M |
|
32
Gyre Therapeutics
GYRE
$734M
| – | – |
-865,773
| Closed | -$1.05M |
|